As of 2026-05-27, the Intrinsic Value of Biocon Ltd (BIOCON.NS) is 25.19 INR. This BIOCON.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 436.15 INR, the upside of Biocon Ltd is -94.20%.
The range of the Intrinsic Value is 5.13 - 58.82 INR
Based on its market price of 436.15 INR and our intrinsic valuation, Biocon Ltd (BIOCON.NS) is overvalued by 94.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5.13 - 58.82 | 25.19 | -94.2% |
| DCF (Growth 10y) | 103.79 - 219.41 | 147.22 | -66.2% |
| DCF (EBITDA 5y) | 472.76 - 611.83 | 560.45 | 28.5% |
| DCF (EBITDA 10y) | 526.52 - 732.48 | 644.43 | 47.8% |
| Fair Value | 11.91 - 11.91 | 11.91 | -97.27% |
| P/E | 63.63 - 88.16 | 72.92 | -83.3% |
| EV/EBITDA | 340.63 - 429.66 | 392.02 | -10.1% |
| EPV | 128.32 - 164.50 | 146.41 | -66.4% |
| DDM - Stable | 15.29 - 31.99 | 23.64 | -94.6% |
| DDM - Multi | 78.18 - 126.16 | 96.48 | -77.9% |
| Market Cap (mil) | 706,270.75 |
| Beta | 0.29 |
| Outstanding shares (mil) | 1,619.33 |
| Enterprise Value (mil) | 825,614.75 |
| Market risk premium | 8.31% |
| Cost of Equity | 12.80% |
| Cost of Debt | 9.75% |
| WACC | 11.73% |